Bariatric surgery reduces CD36-bearing microvesicles of endothelial and monocyte origin

BACKGROUND: Bariatric surgery is a widely adopted treatment for obesity and its secondary complications. In the past decade, microvesicles (MVs) and CD36 have increasingly been considered as possible biomarkers for obesity, the metabolic syndrome (MetSy), type 2 diabetes mellitus (T2DM). Thus, the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Botha, Jaco, Nielsen, Morten Hjuler, Christensen, Maja Høegh, Vestergaard, Henrik, Handberg, Aase
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199798/
https://www.ncbi.nlm.nih.gov/pubmed/30386406
http://dx.doi.org/10.1186/s12986-018-0309-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199798/
https://www.ncbi.nlm.nih.gov/pubmed/30386406
http://dx.doi.org/10.1186/s12986-018-0309-4

Ejemplares similares